Titel

Merkliste
1 Ergebnisse

Filgotinib versus placebo or adalimumab in patients with rh..:

Combe, Bernard ; Kivitz, Alan ; Tanaka, Yoshiya...
info:eu-repo/semantics/altIdentifier/doi/10.1136/annrheumdis-2020-219214. , 2021

Link: https://hal.science/hal-03663886

RT Journal
T1 <Title>Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunimontpellier:oai:HAL:hal-03663886v1&Exemplar=1&LAN=DE
				
A1 Combe, Bernard
A1 Kivitz, Alan
A1 Tanaka, Yoshiya
A1 van Der Heijde, Désirée
A1 Simon, J Abraham
A1 Baraf, Herbert
A1 Kumar, Uma
A1 Matzkies, Franziska
A1 Bartok, Beatrix
A1 Ye, Lei
A1 Guo, Ying
A1 Tasset, Chantal
A1 Sundy, John
A1 Jahreis, Angelika
A1 Genovese, Mark
A1 Mozaffarian, Neelufar
A1 Landewé, Robert
A1 Bae, Sang-Cheol
A1 Keystone, Edward
A1 Nash, Peter
PB HAL CCSD; BMJ Publishing Group
YR 2021
K1 antirheumatic agents
K1 arthritis
K1 rheumatoid
K1 therapeutics
K1 MESH: Adalimumab
K1 MESH: Adult
K1 MESH: Drug Therapy
K1 Combination
K1 MESH: Female
K1 MESH: Humans
K1 MESH: Male
K1 MESH: Methotrexate
K1 MESH: Middle Aged
K1 MESH: Pyridines
K1 MESH: Triazoles
K1 MESH: Aged
K1 MESH: Antirheumatic Agents
K1 MESH: Arthritis
K1 MESH: Double-Blind Method
K1 [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system
K1 [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy
JF info:eu-repo/semantics/altIdentifier/doi/10.1136/annrheumdis-2020-219214
LK http://dx.doi.org/https://hal.science/hal-03663886
DO https://hal.science/hal-03663886
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)